A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/19 (2006.01) C07K 14/52 (2006.01) G01N 33/569 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2328503
The present invention concerns a pharmaceutical composition for the treatment of an MMR virus mediated disease comprising a soluble dialysed leucocyte extract comprising a transfer factor (TF) formed by the dialysis of virus- specific lymphocytes to a molecular weight filter cut-off of 12,500 disposed in a pharmaceutically acceptable carrier or diluent therefor.
L'invention concerne une composition pharmaceutique servant à traiter une maladie provoquée par un virus de ROR et contenant un extrait de leucocyte soluble dialysé comprenant un facteur de transfert (TF) produit par la dialyse de lymphocytes spécifiques au virus à un seuil de rétention moléculaire de 12.500 dans un véhicule ou un diluant acceptable sur le plan pharmaceutique.
Fundenburg Hugh
Wakefield Andrew Jeremy
Adams Thomas
Fundenburg Hugh
Neuroimmuno Therapeutics Research Foundation
Royal Free Hospital School Of Medicine
Wakefield Andrew Jeremy
LandOfFree
Pharmaceutical composition containing transfer factor for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing transfer factor for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing transfer factor for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1801657